5-{[2-({4-[1-(2-Hydroxyethyl)-4-piperidinyl]benzoyl}amino)-4-pyridinyl]oxy}-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide

1622204-21-0

1H-Indole-1-carboxamide, 5-[[2-[[4-[1-(2-hydroxyethyl)-4-piperidinyl]benzoyl]amino]-4-pyridinyl]oxy]-6-(2-methoxyethoxy)-N-methyl-

5-{[2-({4-[1-(2-Hydroxyethyl)-4-piperidinyl]benzoyl}amino)-4-pyridinyl]oxy}-6-(2-methoxyethoxy)-N-methyl-1H-indol-1-carboxamid

5-{[2-({4-[1-(2-Hydroxyethyl)-4-piperidinyl]benzoyl}amino)-4-pyridinyl]oxy}-6-(2-methoxyethoxy)-N-methyl-1H-indole-1-carboxamide

5-{[2-({4-[1-(2-Hydroxyéthyl)-4-pipéridinyl]benzoyl}amino)-4-pyridinyl]oxy}-6-(2-méthoxyéthoxy)-N-méthyl-1H-indole-1-carboxamide

5-[2-[[4-[1-(2-hydroxyethyl)piperidin-4-yl]benzoyl]amino]pyridin-4-yl]oxy-6-(2-methoxyethoxy)-N-methylindole-1-carboxamide

Fgf/fgfr pathway inhibitor E7090

FGFR1_HUMAN

FGFR2_HUMAN

FGFR3_HUMAN

FGFR4_HUMAN

Fibroblast growth factor 2

Fibroblast growth factor receptor 1

Fibroblast growth factor receptor 2

Fibroblast growth factor receptor 3

Fibroblast growth factor receptor 4

tasurgratinib

US8933099, 22::US9951047, Compound (I)